Elevance Health schedules results. Elevance Health stock trades at EUR 380.80
Published on 10/18/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults timing and market level
- Elevance Health scheduled third-quarter results for October 21, 2026.
- Elevance Health stock was quoted at EUR 380.80 at 5:28 p.m. CEST on October 18, 2026.
- The next Xetra session is scheduled for October 19, 2026.
Elevance Health scheduled its third-quarter 2026 results release for October 21, 2026, according to the company’s October 5 press release. Elevance Health stock was quoted at EUR 380.80 in weekend trading at Lang & Schwarz at 5:28 p.m. CEST on October 18, 2026.
Market context: Market report S&P 500.
The week in figures
Lang & Schwarz showed a bid of EUR 380.00 and an ask of EUR 381.60 at 5:28 p.m. CEST on October 18, 2026. Xetra and the primary exchanges were closed during the publication phase.
The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Chronology of the week
October 18, 2026: Elevance Health stock was quoted at EUR 380.80 in weekend trading at Lang & Schwarz at 5:28 p.m. CEST.
Dates of the coming week
Elevance Health said its third-quarter 2026 financial results will be released on October 21, 2026, at 6:00 a.m. Eastern Daylight Time. Management is scheduled to discuss the results and its outlook during a conference call at 8:30 a.m. Eastern Daylight Time, according to the company’s investor-relations release.
The next Xetra session is scheduled for October 19, 2026.
